ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 1 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,389 | -91.8% | 9,047 | -91.1% | 0.00% | – |
| Q2 2023 | $162,768 | +270.3% | 101,098 | +566.9% | 0.00% | – |
| Q1 2023 | $43,961 | -83.3% | 15,159 | -81.1% | 0.00% | – |
| Q4 2022 | $263,446 | -13.3% | 80,319 | 0.0% | 0.00% | – |
| Q3 2022 | $304,000 | -49.9% | 80,319 | +3.0% | 0.00% | – |
| Q2 2022 | $607,000 | -14.1% | 77,952 | +2.5% | 0.00% | – |
| Q1 2022 | $707,000 | -40.2% | 76,059 | +1.4% | 0.00% | – |
| Q4 2021 | $1,183,000 | +14.3% | 75,027 | +29.8% | 0.00% | – |
| Q3 2021 | $1,035,000 | +52.2% | 57,787 | +32.1% | 0.00% | – |
| Q2 2021 | $680,000 | +4.8% | 43,740 | -3.2% | 0.00% | – |
| Q1 2021 | $649,000 | -39.8% | 45,170 | -17.7% | 0.00% | – |
| Q4 2020 | $1,078,000 | +124.1% | 54,912 | +48.0% | 0.00% | – |
| Q3 2020 | $481,000 | -12.9% | 37,103 | -2.1% | 0.00% | – |
| Q2 2020 | $552,000 | +82.8% | 37,898 | +7.0% | 0.00% | – |
| Q1 2020 | $302,000 | -51.6% | 35,410 | -6.5% | 0.00% | – |
| Q4 2019 | $624,000 | +110.8% | 37,873 | +80.7% | 0.00% | – |
| Q3 2019 | $296,000 | -16.9% | 20,954 | +18.4% | 0.00% | – |
| Q2 2019 | $356,000 | -47.3% | 17,699 | +4.2% | 0.00% | – |
| Q1 2019 | $675,000 | +15.6% | 16,991 | +1.1% | 0.00% | – |
| Q4 2018 | $584,000 | -10.8% | 16,809 | +6.2% | 0.00% | – |
| Q3 2018 | $655,000 | +176.4% | 15,826 | +145.9% | 0.00% | – |
| Q2 2018 | $237,000 | -2.5% | 6,435 | +3.7% | 0.00% | – |
| Q1 2018 | $243,000 | +120.9% | 6,207 | -1.9% | 0.00% | – |
| Q4 2017 | $110,000 | -4.3% | 6,326 | -9.6% | 0.00% | – |
| Q3 2017 | $115,000 | +35.3% | 6,994 | +17.4% | 0.00% | – |
| Q2 2017 | $85,000 | -29.2% | 5,958 | 0.0% | 0.00% | – |
| Q1 2017 | $120,000 | +39.5% | 5,958 | -1.6% | 0.00% | – |
| Q4 2016 | $86,000 | +14.7% | 6,055 | +69.0% | 0.00% | – |
| Q3 2016 | $75,000 | -6.2% | 3,583 | 0.0% | 0.00% | – |
| Q2 2016 | $80,000 | +63.3% | 3,583 | +44.3% | 0.00% | – |
| Q1 2016 | $49,000 | -22.2% | 2,483 | 0.0% | 0.00% | – |
| Q4 2015 | $63,000 | -23.2% | 2,483 | 0.0% | 0.00% | – |
| Q3 2015 | $82,000 | -36.9% | 2,483 | 0.0% | 0.00% | – |
| Q2 2015 | $130,000 | – | 2,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 800,000 | $11,656,000 | 5.38% |
| Consonance Capital Management LP | 5,238,218 | $76,321,000 | 4.57% |
| BRIDGER MANAGEMENT, LLC | 1,785,784 | $26,019,000 | 2.41% |
| Trellus Management Company, LLC | 150,000 | $2,186,000 | 2.37% |
| MAVERICK CAPITAL LTD | 6,754,102 | $98,407,000 | 2.07% |
| Redmile Group, LLC | 6,843,370 | $99,708,000 | 1.84% |
| Baupost Group | 9,922,030 | $144,564,000 | 1.80% |
| Camber Capital Management LP | 1,400,000 | $20,398,000 | 1.17% |
| Pinz Capital Management, LP | 161,100 | $2,347,000 | 1.08% |
| Artal Group S.A. | 2,500,000 | $36,425,000 | 1.02% |